Delivery Order SPE2DB25D3306-SPE2DB25FUCVZ
- Not listed
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on August 25, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without a set-aside designation, reflecting AmerisourceBergen's ability to compete openly for federal pharmaceutical procurement...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on July 24, 2025, for 60 tablets of Eliquis 2.5 mg with a ceiling value of $1,989.38. This non-competitive delivery order is set to be completed by July 25, 2025, and represents a pharmaceutical supply requisition under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract award supports the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, with no set-aside designation applied. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. This contract represents a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for $1,187.55 to supply 60 tablets of Eliquis 2.5 mg. This order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,097.65 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 2.5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a $25,827.06 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 per package. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.50 on September 3, 2025, for the supply of Eliquis 2.5 mg tablets (60-count package). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $17,742.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor under the agency's pharmaceutical supply chain and fulfills this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCVZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,724.80 to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 2.5 mg tablets, with an ultimate completion date of September 4, 2025. This non-competitive delivery order represents a firm fixed price transaction and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Eliquis, an anticoagulant medication, represents one of the critical pharmaceutical commodities procured through this contract to support Defense Health Agency and other federal healthcare systems. The award reflects the continued reliance on AmerisourceBergen's capabilities as a major pharmaceutical distributor for federal medical procurement needs across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 9/3/25 |